We have described an adenocarcinoma observed as a grossly discrete area within a cystadenofibroma of the ovary. Fewer than 35 cases of malignant cystadenofibroma have been reported. We find our observations lend support to the prevailing thought that these neoplasms most often originate from preexisting cystadenofibromas.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/00007611-198504000-00030 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Ovarian torsion reveals a large hemorrhagic cystadenofibroma in an elderly woman: Diagnostic challenges and imaging characteristics.
Radiol Case Rep
January 2025
Radiology Department, University Mohammed V Rabat, Rabat, Morocco.
Article Synopsis
- A diagnosis of hemorrhagic ovarian cystadenofibroma was established after surgery, which involved detorsion and removal of the affected ovary.
- The case emphasizes the importance of quick surgical action in emergencies like ovarian torsion and the critical role of advanced imaging techniques, like MRI, in accurately diagnosing complex conditions.
Ovarian Cystadenofibroma: An Innocent Tumor Causing Early Postoperative Small Bowel Obstruction and Perforation Peritonitis.
J Midlife Health
April 2024
Department of Pathology and Laboratory Medicine, All India Institute of Medical Sciences, Bibinagar, Telangana, India.
Ovarian serous cystadenofibroma (CAF) is a relatively uncommon variant of benign epithelial tumors of the ovary. It is frequently misdiagnosed as malignant ovarian mass, on both ultrasound (USG) and computed tomography (CT). Although most cases are easily treatable by surgery, some cases can present with life-threatening complications increasing patient morbidity and mortality.
View Article and Find Full Text PDFOvarian serous cystadenofibroma: A rare case report.
Asian J Surg
July 2024
Department of Radiology, Zigong First People's Hospital, Zigong, Sichuan Province, 643000, PR China; Department of Radiology, Affiliated Hospital of North Sichuan Medical College, 637000, Nanchong, Sichuan Province, PR China. Electronic address:
O-RADS scoring system for adnexal lesions: Diagnostic performance on TVUS performed by an expert sonographer and MRI.
Eur J Radiol
December 2023
Département d'Imageries Radiologiques et Interventionnelles Spécialisées (IRIS), Hôpital Tenon, Assistance Publique-Hôpitaux de Paris, France; Sorbonne Université, INSERM U938 Équipe Biologie et Thérapeutiques du Cancer, France. Electronic address:
Rationale And Objective: To determine the diagnostic performance of transvaginal ultrasound (TVUS) performed by an US specialist and MRI based on the O-RADS scoring system.
Materials And Methods: Between March 5th 2013 and December 31st 2021, 227 patients, referred to our center, underwent TVUS and pelvic MRI for characterization of an adnexal lesion proven by surgery or two years of negative follow-up. All lesions were classified according to O-RADS US and O-RADS MRI risk scoring systems.
Giant Ovarian Tumor.
Medicina (Kaunas)
October 2023
Department of Pathology, Fryderyk Chopin University Hospital, F. Szopena 2, 35-055 Rzeszow, Poland.
Giant ovarian tumors are rare, as most cases are diagnosed during routine gynecological check-ups or abdominal ultrasound examinations. They are a challenge for gynecologists and surgeons. Diagnosis in such patients is difficult due to the limitations of the medical apparatus.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!